MedTrace Logo

Using PRP and Cord Blood in Treatment of Covid -19

NCT04393415 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-07-27

No results posted yet for this study

Summary

covid - 19 is a critical viral infection that affects humans

Conditions

  • Virus

Interventions

COMBINATION_PRODUCT

stem cells

giving stem cells to patients with covid - 19

Sponsors & Collaborators

  • Aljazeera Hospital

    lead OTHER

Principal Investigators

  • Mahmoud Alalfy, PhD · Algezeera hospitaland National Research Centre ,Egypt

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-25
Primary Completion
2020-08-25
Completion
2020-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04393415 on ClinicalTrials.gov